China Resources Pharmaceutical Group Ltd
HKEX:3320
Wall Street
Price Targets
Price Targets Summary
China Resources Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.
Revenue
Forecast
Revenue Estimate
China Resources Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 8%.
Operating Income
Forecast
Operating Income Estimate
China Resources Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's operating income is 4%. The projected CAGR for the next 3 years is 11%.
Net Income
Forecast
Net Income Estimate
China Resources Pharmaceutical Group Ltd
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's net income is 2%. The projected CAGR for the next 3 years is 16%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Resources Pharmaceutical Group Ltd's stock price target?
Price Target
7
HKD
According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.
What is China Resources Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's revenue is 6%. The projected CAGR for the next 3 years is 8%.
What is China Resources Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's operating income is 4%. The projected CAGR for the next 3 years is 11%.
What is China Resources Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
16%
For the last 8 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's net income is 2%. The projected CAGR for the next 3 years is 16%.